The dipeptidyl peptidase-4 inhibitor vildagliptin improves beta-cell function and insulin sensitivity in subjects with impaired fasting glucose.
暂无分享,去创建一个
J. Holst | S. Kahn | K. Utzschneider | J. Foley | C. Deacon | J. Tong | S. Marcovina | B. Montgomery | F. Gerchman | C. Watson | J. Udayasankar | M. Ligueros‐Saylan